Maspin expression is regulated by the non-canonical NF-κB subunit in androgen-insensitive prostate cancer cell lines.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Immunology

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molimm.2011.07.013PMID 21856005
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RelB-Dependent Differential Radiosensitization Effect of STI571 on Prostate Cancer Cells

  2010cited by this paper
• The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.

  2010cited by this paper
• Maspin suppresses survival of lung cancer cells through modulation of Akt pathway.

  2010cited by this paper
• Focus on molecules: maspin.

  2010cited by this paper
• The Tumor Suppressor Maspin Mediates E2F1-Induced Sensitivity of Cancer Cells to Chemotherapy

  2010cited by this paper
• Molecular genetics of prostate cancer: new prospects for old challenges.

  2010cited by this paper
• RelB regulates manganese superoxide dismutase gene and resistance to ionizing radiation of prostate cancer cells

  2010cited by this paper
• Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin

  2009cited by this paper
• RelB enhances prostate cancer growth: implications for the role of the nuclear factor-kappaB alternative pathway in tumorigenicity.

  2009cited by this paper
• Regulation and function of NF-kappaB transcription factors in the immune system.

  2009cited by this paper
• Inhibition of RelB by 1,25‐dihydroxyvitamin D3 promotes sensitivity of breast cancer cells to radiation

  2009cited by this paper
• PTEN and p53 are required for hypoxia induced expression of maspin in glioblastoma cells

  2009cited by this paper
• TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.

  2009cited by this paper
• Compensatory IKKα activation of classical NF-κB signaling during IKKβ inhibition identified by an RNA interference sensitization screen

  2008cited by this paper
• Lack of nuclear factor-kappa B2/p100 causes a RelB-dependent block in early B lymphopoiesis.

  2008cited by this paper
• Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin

  2007cited by this paper
• Suppression of RelB-mediated manganese superoxide dismutase expression reveals a primary mechanism for radiosensitization effect of 1α,25-dihydroxyvitamin D3 in prostate cancer cells

  2007cited by this paper
• Tumor suppressor activity of glucocorticoid receptor in the prostate

  2007cited by this paper
• Constitutive alternative NF-kappaB signaling promotes marginal zone B-cell development but disrupts the marginal sinus and induces HEV-like structures in the spleen.

  2007cited by this paper
• Maspin augments proteasome inhibitor‐induced apoptosis in prostate cancer cells

  2007cited by this paper
• Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Maspin in NSCLC.

  2006cited by this paper
• Maspin Expression Is Characteristic for Cisplatin-Sensitive Ovarian Cancer Cells and for Ovarian Cancer Cases of Longer Survival Rates

  2006cited by this paper
• NF-kappaB activation in human prostate cancer: important mediator or epiphenomenon?

  2004cited by this paper
• NF‐κB activation in human prostate cancer: Important mediator or epiphenomenon?

  2004cited by this paper
• Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant IκBα Degradation in B Cells

  2004cited by this paper
• Regulation of constitutive p50/c-Rel activity via proteasome inhibitor-resistant IkappaBalpha degradation in B cells.

  2004cited by this paper
• Bax Mediates the Apoptosis-Sensitizing Effect of Maspin

  2004cited by this paper
• Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway

  2003cited by this paper
• Maspin expression in invasive breast cancer: association with other prognostic factors

  2003cited by this paper
• Maspin expression profile in human prostate cancer (CaP) and in vitro induction of Maspin expression by androgen ablation.

  2002cited by this paper
• p53 Regulates the Expression of the Tumor Suppressor Gene Maspin*

  2000cited by this paper
• Expression of maspin in prostate cells is regulated by a positive ets element and a negative hormonal responsive element site recognized by androgen receptor.

  1997cited by this paper
• Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells.

  1994cited by this paper

• Dietary saturated fatty acids and prostate cancer: insights into NF-κB pathway and lipid metabolism mechanisms

  2025cites this paper
• The induction of Maspin expression by a glucosamine-derivative has an antiproliferative activity in prostate cancer cell lines.

  2019cites this paper
• The nuclear transcription factor RelB functions as an oncogene in human lung adenocarcinoma SPC-A1 cells

  2018cites this paper
• NF-κB: Its Role in Pancreatic Cancer

  2017cites this paper
• The NF-κB subunit RelB regulates the migration and invasion abilities and the radio-sensitivity of prostate cancer cells.

  2016cites this paper
• miR-1792 plays an oncogenic role and conveys chemo ‐ resistance to cisplatin in human prostate cancer cells

  2016cites this paper
• miR-17-92 plays an oncogenic role and conveys chemo-resistance to cisplatin in human prostate cancer cells.

  2016cites this paper
• The IKKα-dependent non-canonical pathway of NF-κB activation is constitutively active and modulates progression-related functions in a subset of human melanomas

  2016cites this paper
• Recent insights into NF‐κB signalling pathways and the link between inflammation and prostate cancer

  2014cites this paper
• NF-kappaB2/p52 in Prostate Cancer

  2013cites this paper
• RelB, together with RelA, sustains cell survival and confers proteasome inhibitor sensitivity of chronic lymphocytic leukemia cells from bone marrow

  2013cites this paper